The Valvular Interventions Center

Filter Your Results

 

News

 

Innovative Cardiovascular Solutions Begins European Study of the Emblok Embolic Protection System

March 15, 2017 -- Innovative Cardiovascular Solutions (ICS) announced the successful first European clinical cases using the company's Emblok embolic protection syste…

Medtronic's Melody TPV Approved for Implantation in Failed Surgical Pulmonary Heart Valves

March 14, 2017 -- Medtronic announced that its Melody transcatheter pulmonary valve (TPV) received approval from the US Food and Drug Administration for implantation in patien…

Keystone Heart Partners With Venus Medtech in China and Key Asian Markets

March 2, 2017 -- Keystone Heart Ltd., an Israel-based developer of cerebral embolic protection devices for patients undergoing cardiac procedures, and Venus Medtech (Hangzhou)…

FDA Panel Reviews Claret Medical's Sentinel Cerebral Protection System for TAVR

February 27, 2017 -- Claret Medical Inc. announced that in an open public hearing of the US Food and Drug Administration's Circulatory System Devices Panel held on Februar…

Boston Scientific Voluntarily Recalls All Lotus TAVR Devices

February 23, 2017 -- In a Form 8-K report to the US Securities and Exchange Commission (SEC), Boston Scientific announced a voluntary removal of all Lotus transcathe…

An Interview With Josep Rodés-Cabau, MD

January/February 2017—Dr. Rodés-Cabau discusses the current landscape of transcatheter valve technologies, as well as his participation in innovative structural heart interventions.

Study Evaluates Balloon Postdilation in CoreValve TAVR Trials

February 3, 2017 -- A study of the impact of balloon postdilation (BPD) on outcomes in the United States clinical trials for the CoreValve transcatheter aortic valve replaceme…

Transcaval Access and Closure Studied for TAVR

January 30, 2017 -- Adam B. Greenbaum, MD, et al conducted an investigation to determine if transcaval access could enable fully percutaneous transcatheter aortic valve r…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.